Stay updated on Immunotherapy in Stage IV Melanoma Patients Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Two screenshots show the same study details page with no core-content changes; only metadata such as update dates appears different.
    Difference
    0.4%
    Check dated 2025-11-03T01:22:25.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now states potential funding-related delays and current NIH Clinical Center operating status, and updates the version to v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T10:29:56.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:23:27.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:43:27.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.
    Difference
    0.2%
    Check dated 2025-09-06T15:28:05.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information related to immunotherapy, specifically for Ipilimumab, Pembrolizumab, and Nivolumab, while removing several previous references to locations and certain medical topics.
    Difference
    4%
    Check dated 2025-08-30T12:14:45.000Z thumbnail image

Stay in the know with updates to Immunotherapy in Stage IV Melanoma Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Stage IV Melanoma Patients Clinical Trial page.